Background: Despite the high prevalence and large number of studies on chronic bacterial prostatitis, no effective treatment has been found for this disease. Aim: To compare the therapeutic effect of ciprofloxacin and the combination of propolis and ciprofloxacin on patients with chronic bacterial prostatitis. Methods: This study was performed as a single-blind randomized clinical trial. 190 men with chronic bacterial prostatitis in Qom in 2018-2019 who met the inclusion criteria, formed the statistical population of this study and the samples were selected by census of patients with bacterial prostatitis by the available method. The subjects were randomly assigned to 2 groups receiving ciprofloxacin and a combination of ciprofloxacin and propolis. Blood and urine sampling was performed at the beginning of the study and at the end of the 30-day treatment period. Data analysis was performed using SPSS software version 16 and the significance level was considered to be less than 0.05. Results: The data obtained from WBC and ESR analysis of patients in both groups before and after the study did not show a significant difference. In the study of International Prostatic Symptoms Score, there was no significant difference between the severity of symptoms before treatment in different parameters, but after studying the severity of symptoms and their improvement showed a significant difference. In the first group, 45.7% but in the propolis group, 63.5% improvement was achieved. Based on the pain measurement criteria, the severity of pelvic pain in the two groups before the study was not significantly different, but after the study, the observed difference between the two groups was significant. Based on the results, the rate of pain relief in the first group was 51% and in the second group was 65.8%. Conclusion: Propolis as an anti-inflammatory and immune system booster, antimicrobial, antioxidant, anti-tumor, without any side effects can be used in the treatment of chronic infections and inflammation.